Boothbay Fund Management, LLC Heron Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $74,345 - $203,317	-32,324 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $17,890 - $38,408	3,864 Added 13.58%	32,324 $185,000
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $78,222 - $118,036	-9,368 Reduced 24.76%	28,460 $260,000
Q3 2021 Nov 15, 2021	BUY	$10.13 - $15.0 $278,676 - $412,650	27,510 Added 266.62%	37,828 $404,000
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $136,919 - $190,676	10,318 New	10,318 $160,000

Q2 2020 Aug 14, 2020	SELL	$10.89 - $21.47 $143,748 - $283,404	-13,200 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$10.23 - $24.56 $135,036 - $324,192	13,200 New	13,200 $155,000

168

119M

151K

103K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $416M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.